Title:
SUPER FAST-ACTING INSULIN COMPOSITIONS
Document Type and Number:
Japanese Patent JP2016034959
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide alternative insulin compositions that more effectively mimic the endogenous insulin response when administered to a subject, leading to more effective glycemic control and a reduction in negative side-effects of insulin therapy.SOLUTION: Provided are combinations, compositions and kits containing a fast-acting insulin composition and a hyaluronan degrading enzyme composition formulated for parenteral administration. Such products can be used in methods of treating insulin-treatable diseases or conditions. Also provided are methods for administration of a fast-acting insulin and a hyaluronan degrading enzyme.SELECTED DRAWING: Figure 1
More Like This:
| JP2009545303 | Diabetes test |
| JPS58113140 | NAPHTHOXYALKYL COMPOUND, MANUFACTURE AND ANTIINFLAMMATORY THEREFROM |
| WO/1992/012999 | NOVEL INSULIN ANALOGS |
Inventors:
FROST GREGORY I
IGOR BILINSKY
DANIEL VAUGHN
BARRY SUGARMAN
IGOR BILINSKY
DANIEL VAUGHN
BARRY SUGARMAN
Application Number:
JP2015178801A
Publication Date:
March 17, 2016
Filing Date:
September 10, 2015
Export Citation:
Assignee:
HALOZYME INC
International Classes:
A61K38/28; A61K9/08; A61K38/46; A61P3/10; A61P43/00; C07K14/62; C12N9/26
Domestic Patent References:
| JP2006524507A | 2006-11-02 |
Foreign References:
| WO2006091871A1 | 2006-08-31 |
Other References:
JPN5011003586; ＨＥＬＬＥＲ，Ｓ． ｅｔ ａｌ: 'ＩＮＳＵＬＩＮ'Ｓ ８５ＴＨ ＡＮＮＩＶＥＲＳＡＲＹ-ＡＮ ＥＮＤＵＲＩＮＧ ＭＥＤＩＣＡＬ ＭＩＲＡＣＬＥ' ＤＩＡＢＥＴＥＳ ＲＥＳＥＡＲＣＨ ＡＮＤ ＣＬＩＮＩＣＡＬ ＰＲＡＣＴＩＣＥ Ｖｏｌ．７８， Ｎｏ．２, 20070926, ｐ．１４９-１５８
JPN5011003582; ＨＡＬＬＥＲ，Ｍ．: 'ＣＯＮＶＥＲＴＩＮＧ ＩＮＴＲＡＶＥＮＯＵＳ ＤＯＳＩＮＧ ＴＯ ＳＵＢＣＵＴＡＮＥＯＵＳ ＤＯＳＩＮＧ： ＷＩＴＨ ＲＥＣＯＭＢＩＮＡＮＴ ＨＵＭＡＮ ＨＹＡＬＵＲＯＮＩＤＡＳＥ' ＰＨＡＲＭＡＣＥＵＴＩＣＡＬ ＴＥＣＨＮＯＬＯＧＹ Ｖｏｌ．３１， Ｎｏ．１２, 20071201, ｐ．１１８，１２０，１２２，１２４，１２６，１２８，１３０，１３２, ＡＤＶＡＮＳＴＡＲ ＣＯＭＭＵＮＩＣＡＴＩＯＮＳ ＩＮＣ．
JPN5011003580; ＢＯＯＫＢＩＮＤＥＲ，Ｌ．Ｈ． ｅｔ ａｌ: 'Ａ ＲＥＣＯＭＢＩＮＡＮＴ ＨＵＭＡＮ ＥＮＺＹＭＥ ＦＯＲ ＥＮＨＡＮＣＥＤ ＩＮＴＥＲＳＴＩＴＩＡＬ ＴＲＡＮＳＰＯＲＴ ＯＦ ＴＨＥＲＡＰＥＵＴＩＣＳ' ＪＯＵＲＮＡＬ ＯＦ ＣＯＮＴＲＯＬＬＥＤ ＲＥＬＥＡＳＥ Ｖｏｌ．１１４， Ｎｏ．２, 20060828, ｐ．２３０-２４１, ＥＬＳＥＶＩＥＲ
JPN5011003582; ＨＡＬＬＥＲ，Ｍ．: 'ＣＯＮＶＥＲＴＩＮＧ ＩＮＴＲＡＶＥＮＯＵＳ ＤＯＳＩＮＧ ＴＯ ＳＵＢＣＵＴＡＮＥＯＵＳ ＤＯＳＩＮＧ： ＷＩＴＨ ＲＥＣＯＭＢＩＮＡＮＴ ＨＵＭＡＮ ＨＹＡＬＵＲＯＮＩＤＡＳＥ' ＰＨＡＲＭＡＣＥＵＴＩＣＡＬ ＴＥＣＨＮＯＬＯＧＹ Ｖｏｌ．３１， Ｎｏ．１２, 20071201, ｐ．１１８，１２０，１２２，１２４，１２６，１２８，１３０，１３２, ＡＤＶＡＮＳＴＡＲ ＣＯＭＭＵＮＩＣＡＴＩＯＮＳ ＩＮＣ．
JPN5011003580; ＢＯＯＫＢＩＮＤＥＲ，Ｌ．Ｈ． ｅｔ ａｌ: 'Ａ ＲＥＣＯＭＢＩＮＡＮＴ ＨＵＭＡＮ ＥＮＺＹＭＥ ＦＯＲ ＥＮＨＡＮＣＥＤ ＩＮＴＥＲＳＴＩＴＩＡＬ ＴＲＡＮＳＰＯＲＴ ＯＦ ＴＨＥＲＡＰＥＵＴＩＣＳ' ＪＯＵＲＮＡＬ ＯＦ ＣＯＮＴＲＯＬＬＥＤ ＲＥＬＥＡＳＥ Ｖｏｌ．１１４， Ｎｏ．２, 20060828, ｐ．２３０-２４１, ＥＬＳＥＶＩＥＲ
Attorney, Agent or Firm:
Mitsuo Tanaka
Hiroshi Yamazaki
Kenji Tomita
Manami Sasakura
Hiroshi Yamazaki
Kenji Tomita
Manami Sasakura
Previous Patent: STABLE MIA/CD-RAP FORMULATION
Next Patent: METHODS, COMPOUNDS AND COMPOSITIONS FOR DELIVERING 1,3-PROPANEDISULFONIC ACID
Next Patent: METHODS, COMPOUNDS AND COMPOSITIONS FOR DELIVERING 1,3-PROPANEDISULFONIC ACID